EUCTR2005-001982-33-SE进行中（未招募）不适用
An open label study of Zonegran (zonisamide) in patients with partial onset seizures.
适应症
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 入组人数
- 1,000
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •1) Male or female adult patients aged 18-75
- •2) Able and willing to give written informed consent in accordance with the ICH GCP Guidelines.
- •3) Female subjects of childbearing potential must not be pregnant (as confirmed by negative serum ßHCG at screening and negative urine pregnancy test at baseline ), must not be lactating and must use a medically acceptable form of contraception during the study and for at least 1 month after discontinuation of study drug. Medically acceptable contraception as defined here is the oral contraceptive pill, surgical sterilization or adequate barrier methods (i.e. a condom and spermicide, intrauterine device in place for at least 3 months or diaphragm and foam). Women who are less than 2 years post menopausal are considered to be of childbearing potential.
- •4) Focal epilepsy, with simple and/or complex partial seizures with or without secondary generalized seizures as defined by the ILAE criteria.
- •5) Patients with a minimum of 4 partial seizures in the 8 weeks preceding the baseline visit as adequately recorded using a seizure diary card.
- •6) Patients should be receiving at least 1 but no more than 2 other AEDs as concomitant medication, and the dosage should be stable for at least 8 weeks before the baseline visit.
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range
排除标准
- •1) History of status epilepticus within the last 5 years
- •2) Patients with known significantly impaired renal function and/or severe hepatic impairment to the extent that the protocol dose titration schedule cannot be followed. Note investigators should consult included SmPC as a guide.
- •3) Patients suffering from clinically significant psychiatric illness, psychological or behavioral problems which could interfere with study participation.
- •4) Patients with a history (within the last 12 months) of alcohol or drug abuse or dependency.
- •5) Patient suffering from any CNS progressive disease that may confound study interpretation, any active CNS infection, demyelinating disease or degenerative neurological disease.
- •6) Patients with a significant drug sensitivity or significant allergic reaction to any drug including sulphonamides.
- •7)Subjects considered by the investigator to be an unsuitable candidate for receiving zonisamide or considered unlikely to comply with the protocol.
- •8) Any patient contraindicated for ZonegranTM treatment as per attached SmPC
研究者
相似试验
进行中（未招募）
1 期
An open label study of Zonegran (zonisamide) in patients with partial onset seizures.Indicated as adjunctive therapy in the treatment of adult patients with partial seizures, with or without secondary generalisation.MedDRA version: 8.0 Level: pt Classification code 10061334EUCTR2005-001982-33-GBEisai Limited1,000
进行中（未招募）
不适用
An open label study of Zonegran (zonisamide) in patients with partial onset seizures.Indicated as adjunctive therapy in the treatment of adult patients with partial seizures, with or without secondary generalisation.MedDRA version: 8.0Level: PTClassification code 10061334EUCTR2005-001982-33-DKEisai Limited1,000
进行中（未招募）
不适用
An open label study of Zonegran (zonisamide) in patients with partial onset seizures. - ZEUSIndicated as adjunctive therapy in the treatment of adult patients with partial seizures, with or without secondary generalisation.MedDRA version: 8.0Level: PTClassification code 10061334EUCTR2005-001982-33-FIEisai Limited1,000
进行中（未招募）
不适用
An open label study of Zonegran (zonisamide) in patients with partial onset seizures.Indicated as adjunctive therapy in the treatment of adult patients with partial seizures, with or without secondary generalisation.MedDRA version: 8.0Level: PTClassification code 10061334EUCTR2005-001982-33-DEEisai Limited1,000
进行中（未招募）
不适用
An open label study of ZonegranTM (zonisamide) in patients with partial onset seizures.EUCTR2005-001982-33-ATEisai Limited1,000